Utilization and Outcomes of the 21-Gene Recurrence Score in pN2 Breast Cancer Patients.
Saved in:
| Title: | Utilization and Outcomes of the 21-Gene Recurrence Score in pN2 Breast Cancer Patients. |
|---|---|
| Authors: | Haque W; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A.; waqarh786@gmail.com., Verma V; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A., Mangalampalli N; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A., Schwartz MR; Department of Pathology, Houston Methodist Hospital, Houston, TX, U.S.A., Butler EB; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A., Sun K; Department of Medical Oncology, Houston Methodist Hospital, Houston, TX, U.S.A., Jain D; Department of Medical Oncology, Houston Methodist Hospital, Houston, TX, U.S.A., Arentz C; Department of Surgery, Houston Methodist Hospital, Houston, TX, U.S.A., Ramakrishnan A; Department of Radiation Oncology, University of Texas Medical Branch, Galveston, TX, U.S.A., Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A. |
| Source: | Anticancer research [Anticancer Res] 2025 Mar; Vol. 45 (3), pp. 1055-1061. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
